Induction of Mdm2 and enhancement of cell survival by bFGF

被引:94
作者
Shaulian, E [1 ]
Resnitzky, D [1 ]
Shifman, O [1 ]
Blandino, G [1 ]
Amsterdam, A [1 ]
Yayon, A [1 ]
Oren, M [1 ]
机构
[1] WEIZMANN INST SCI,DEPT MOL CELL BIOL,IL-76100 REHOVOT,ISRAEL
关键词
Mdm2; bFGF; p53; apoptosis; cisplatin;
D O I
10.1038/sj.onc.1201453
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Basic fibroblast growth factor (bFGF) can exert mitogenic and viability-promoting effects in a wide range of biological systems. The biochemical activities mediating the cell survival function of bFGF are largely unknown. We report here that exposure of fibroblasts to bFGF, which confers upon them increased survival, also causes at the same time an increase in cellular levels of the Mdm2 oncoprotein. Cells constitutively exposed to a bFGF autocrine loop are more refractory to killing by cisplatin. This increased chemoresistance coincides with elevated Mdm2 and reduced activation of the endogenous p53, resulting in inefficient transcriptional activation of the bar gene promoter. Importantly, unlike Mdm2 accumulation in fibroblasts exposed to DNA damage, induction of Mdm2 by bFGF does not occur through a p53-mediated pathway. The role of p53 in DNA damage-induced apoptosis and the ability of Mdm2 to block p53-mediated cell death are well established. These findings therefore suggest that induction of Mdm2 and the subsequent inhibition of p53 function may contribute, at least partially, to the anti-apoptotic effects of bFGF and possibly some other survival factors.
引用
收藏
页码:2717 / 2725
页数:9
相关论文
共 96 条
[61]  
MIYASHITA T, 1995, CELL, V80, P293
[62]   A TYROSINE-PHOSPHORYLATED CARBOXY-TERMINAL PEPTIDE OF THE FIBROBLAST GROWTH-FACTOR RECEPTOR (FLG) IS A BINDING-SITE FOR THE SH2 DOMAIN OF PHOSPHOLIPASE C-GAMMA-1 [J].
MOHAMMADI, M ;
HONEGGER, AM ;
ROTIN, D ;
FISCHER, R ;
BELLOT, F ;
LI, W ;
DIONNE, CA ;
JAYE, M ;
RUBINSTEIN, M ;
SCHLESSINGER, J .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (10) :5068-5078
[63]   THE MDM-2 ONCOGENE PRODUCT FORMS A COMPLEX WITH THE P53 PROTEIN AND INHIBITS P53-MEDIATED TRANSACTIVATION [J].
MOMAND, J ;
ZAMBETTI, GP ;
OLSON, DC ;
GEORGE, D ;
LEVINE, AJ .
CELL, 1992, 69 (07) :1237-1245
[64]  
Momand J, 1996, ONCOGENE, V12, P2279
[65]  
Momand J, 1997, J CELL BIOCHEM, V64, P343
[66]  
MOSNER J, 1994, ONCOGENE, V9, P3321
[67]   ONCOPROTEIN MDM2 CONCEALS THE ACTIVATION DOMAIN OF TUMOR SUPPRESSOR-P53 [J].
OLINER, JD ;
PIETENPOL, JA ;
THIAGALINGAM, S ;
GVURIS, J ;
KINZLER, KW ;
VOGELSTEIN, B .
NATURE, 1993, 362 (6423) :857-860
[68]   AMPLIFICATION OF A GENE ENCODING A P53-ASSOCIATED PROTEIN IN HUMAN SARCOMAS [J].
OLINER, JD ;
KINZLER, KW ;
MELTZER, PS ;
GEORGE, DL ;
VOGELSTEIN, B .
NATURE, 1992, 358 (6381) :80-83
[69]  
OREN M, 1994, SEMIN CANCER BIOL, V5, P221
[70]  
OTTO A, 1993, ONCOGENE, V8, P2591